Mission

To develop precision medicines that target hypoxic (low oxygen) areas in tumours that conventional chemotherapy, immunotherapy and radiotherapy do not treat. Hypoxia is recognized as a key resistance factor affecting all cancer treatments

Roland Z. Kozlowski

PhD, Chairman of the Board & Commercial Director

Roland is a seasoned Life Science Industry professional with a great understanding of the Polish Life Science Eco-System from the perspective of a Western practitioner.

Stefan Ogrodzinski

MBA, Chief Executive Officer

Stefan Ogrodzinski is an experienced CEO and Board Director with a 25-year career spanning the pharmaceutical industry, healthcare, voluntary and educational sectors.

Professor Paul Smith

Chief Scientific Officer

Paul is Professor Emeritus of Cancer Biology with over 30 years of international research experience in the fields of DNA repair, radiobiology, drug targeting and development and cytometry publishing over 200 papers and patents.

Professor Laurence Patterson

Chief Operating Officer

Laurence Patterson is professor emeritus of drug discovery with over 30 years’ experience of research in UK pharma and academia. He gained his BSc (Hons) from Hertfordshire University and PhD from the Chelsea Department of Pharmacy.

Dr Thomas Morris

Chief Medical Officer

Dr Thomas Morris received his BSc in Physiology from the University of Wales in 1984, his medical degrees in 1987 from the University of Wales College of Medicine, and his Master of Laws degree from Cardiff Law School in 2009.

Professor Stephanie McKeown

Project Director

BA (Oxon), PhD, CBiol MIBiol – Project Director – is an Internationally recognized radiobiology expert with main research interests focused around tumour radiobiology with particular reference to hypoxia and the role of the tumour microvasculature in treatment response.

Justyna Supel

Operational Director Poland

Justyna Supel is an experienced Operations and Compliance Executive with an excellent understanding of public funding processes in the commercial and public sector.

Kinga Drechny

Marketing & Communication Director

Kinga is a seasoned professional of Marketing and Communication activities in various industries. She holds a Master’s Degree in Law & Administration and a Batchelors Degree in Marketing and Communication both from the Jagiellonian University in Krakow.

Contact

OncoTherics Poland Spółka Akcyjna
ul. prof. Michała Bobrzyńskiego 14
30-348 Kraków
Poland

Copyright © 2010 - 2020 All rights reserved